Our two core businesses include: Medical Device Coatings – lubricious hydrophilic coatings, hemocompatible hydrophilic coatings, and advanced drug delivery systems; and In Vitro Diagnostics (IVD) – immunoassay reagents that improve the performance of in vitro diagnostic tests as well as custom coatings and stabilization products for Molecular Diagnostic applications.

Eden Prairie, US
Size (employees)
219 (est)+31%
SurModics was founded in 1979 and is headquartered in Eden Prairie, US

SurModics Office Locations

SurModics has an office in Eden Prairie
Eden Prairie, US (HQ)
9924 W 74th St
Eden Prairie, US
123 9700 W 76th St

SurModics Data and Metrics

SurModics Financial Metrics

SurModics's revenue was reported to be $71.4 m in FY, 2016 which is a 15% increase from the previous period.

Revenue (FY, 2016)

71.4 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

60.5 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

10 m

Market capitalization (21-Jul-2017)

374 m

Cash (30-Sep-2016)

25 m
SurModics's current market capitalization is $374 m.
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


51.9 m56.1 m57.4 m61.9 m71.4 m

Revenue growth, %


Cost of goods sold

6.8 m6.8 m7.4 m7.9 m8 m8.6 k10.9 m

Gross profit

44.5 m48.2 m49.4 m61.9 m60.5 m

Gross profit Margin, %


R&D expense

3.9 m5.2 m18.5 m

General and administrative expense

13.9 m15.5 m18 m

Operating expense total

37.3 m42.8 m54.5 m

Pre tax profit

20.4 m18.2 m16.9 m

Income tax expense

5 m5.6 m6.2 m(5.8 m)6.3 m(6.3 m)(7 m)

Net Income

15.2 m12 m11.9 m10 m
USDY, 2009Y, 2010Y, 2011Y, 2012FY, 2013FY, 2014FY, 2015FY, 2016


11.6 m11.4 m23.2 m15.5 m15.5 m43.5 m55.6 m25 m

Accounts Receivable

1.7 b670.9 b


3.3 m2.8 m3 m3.6 m

Current Assets

35.8 m55.3 m67.8 m58.6 m


12.8 m13.1 m13 m19.6 m


8 m8 m8 m26.6 m

Total Assets

101.9 m104.9 m98.7 m132.9 m

Accounts Payable

954 k1 m781 k1.6 m

Current Liabilities

6 m4.1 m4.7 m10.1 m

Total Liabilities

26.1 m

Additional Paid-in Capital

2 m2.7 m3.1 m6.8 m

Retained Earnings

91 m93.9 m88.2 m98.1 m

Total Equity

93.8 m98.8 m91.9 m106.8 m

Financial Leverage

1.1 x1.1 x1.1 x1.2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

15.2 m12 m11.9 b10 m

Depreciation and Amortization

2.9 m2.7 m2.8 m4.9 m

Accounts Receivable

(263 k)581 k(2.7 m)911 k


196 k511 k(162 k)(143 k)

Accounts Payable

518 k905 k

Cash From Operating Activities

(116 k)(354 k)(45 k)(45 k)

Purchases of PP&E

(1.9 m)(2.3 m)(1.9 m)(8.2 m)

Cash From Financing Activities

116 k354 k45 k45 k

Income Taxes Paid

(989 k)6.3 m6.5 m6.7 m
Y, 2016

Financial Leverage

1.2 x

SurModics Market Value History

SurModics Company Life and Culture

You may also be interested in